Google DeepMind Unveils AlphaGenome 2 to Map How DNA Changes Affect Cells

Google DeepMind has unveiled AlphaGenome 2, the successor to its genome-predicting AlphaGenome model released last year. The model is designed to show how DNA variations alter gene activity across different cell types, such as heart, skin, and immune cells. Researchers say this could help identify the cellular roots of disease and point toward new treatments.

Why it matters: It shows frontier AI models moving into detailed biological prediction, a capability that could speed drug discovery and disease research built on AI foundation models.